These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16184804)

  • 1. Anxiety management in Arkansas: benzodiazepine prescribing varies dramatically by region.
    Golden WE; Potts SG; West D
    J Ark Med Soc; 2005 Sep; 102(3):58-9. PubMed ID: 16184804
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial disparities in access after regulatory surveillance of benzodiazepines.
    Pearson SA; Soumerai S; Mah C; Zhang F; Simoni-Wastila L; Salzman C; Cosler LE; Fanning T; Gallagher P; Ross-Degnan D
    Arch Intern Med; 2006 Mar; 166(5):572-9. PubMed ID: 16534046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics and clinician attitudes influencing the prescribing of benzodiazepines.
    Heiman EM; Wood G
    J Clin Psychiatry; 1981 Feb; 42(2):71-3. PubMed ID: 7462173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies.
    Petitjean S; Ladewig D; Meier CR; Amrein R; Wiesbeck GA
    Int Clin Psychopharmacol; 2007 Sep; 22(5):292-8. PubMed ID: 17690598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines prescription in Dakar: a study about prescribing habits and knowledge in general practitioners, neurologists and psychiatrists.
    Dièye AM; Sylla M; Ndiaye A; Ndiaye M; Sy GY; Faye B
    Fundam Clin Pharmacol; 2006 Jun; 20(3):235-8. PubMed ID: 16671957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prescription of benzodiazepines by general practitioners in the private sector of Dakar: survey on knowledge and attitudes].
    Dièye AM; Sy AN; Sy GY; Diallo AA; Diarra M; Ndiaye M; Faye B
    Therapie; 2007; 62(2):163-8. PubMed ID: 17582318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prescribing dilemma of benzodiazepines.
    Sim MG; Khong E; Wain TD
    Aust Fam Physician; 2007 Nov; 36(11):923-6. PubMed ID: 18043779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescriptions for schedule II opioids and benzodiazepines increase after the introduction of computer-generated prescriptions.
    McGerald G; Dvorkin R; Levy D; Lovell-Rose S; Sharma A
    Acad Emerg Med; 2009 Jun; 16(6):508-12. PubMed ID: 19388914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine Utilization in Medicare Beneficiaries by Mohs Surgeons and Dermatologists From 2013 to 2017.
    Patel P; Guzman AK; Routt E; Ciocon D
    Dermatol Surg; 2021 Jun; 47(6):832-834. PubMed ID: 33165056
    [No Abstract]   [Full Text] [Related]  

  • 11. General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application.
    Stewart R; Niessen WJ; Broer J; Snijders TA; Haaijer-Ruskamp FM; Meyboom-De Jong B
    J Clin Epidemiol; 2007 Oct; 60(10):1076-84. PubMed ID: 17884604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia.
    Degenhardt L; Roxburgh A; van Beek I; Hall WD; Robinson MK; Ross J; Mant A
    Drug Alcohol Rev; 2008 Mar; 27(2):145-51. PubMed ID: 18264874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines: the end of a dream.
    Byrne A
    Aust Fam Physician; 1994 Aug; 23(8):1584-5. PubMed ID: 7980158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues and controversies regarding benzodiazepine use.
    Salzman C
    NIDA Res Monogr; 1993; 131():68-88. PubMed ID: 8413544
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder.
    Smolders M; Laurant M; van Rijswijk E; Mulder J; Braspenning J; Verhaak P; Wensing M; Grol R
    Fam Pract; 2007 Dec; 24(6):538-46. PubMed ID: 18003604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic prescribing in Arkansas: compliance with national standards varies widely.
    Golden WE; Wells C
    J Ark Med Soc; 2006 Mar; 102(9):244-5. PubMed ID: 16562761
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a two-day stop-order policy on benzodiazepine prescribing.
    Sketris IS; Meldrum M; Lacey D; Merrett RA
    Am J Hosp Pharm; 1987 Dec; 44(12):2736-8. PubMed ID: 2893550
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.